Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:epalrestat
go back to main search page
Accession:CHEBI:31539 term browser browse the term
Definition:A monocarboxylic acid that is 1,3-thiazolidine which is substituted on the nitrogen by a carboxymethyl group, at positions 2 and 4 by thioxo and oxo groups, respectively, and at position 5 by a 2-methyl-3-phenylprop-2-en-1-ylidene group. It is an inhibitor of aldose reductase (which catalyses the conversion of glucose to sorbitol) and is used for the treatment of some diabetic complications, including neuropathy.
Synonyms:exact_synonym: {(5Z)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid
 related_synonym: 5-((1Z,2E)-2-methyl-3-phenylpropenylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid;   5-((Z,E)-beta-methylcinnamylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid;   Formula=C15H13NO3S2;   InChI=1S/C15H13NO3S2/c1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12/h2-8H,9H2,1H3,(H,17,18)/b10-7+,12-8-;   InChIKey=CHNUOJQWGUIOLD-NFZZJPOKSA-N;   Kinedak;   ONO-2;   ONO-2235;   SMILES=C\\C(\\C=C1/SC(=S)N(CC(O)=O)C1=O)=C/c1ccccc1;   epalrestatum
 xref: CAS:82159-09-9;   Drug_Central:1021;   KEGG:D01688
 xref_mesh: MESH:C038131
 xref: PDBeChem:EPR;   PMID:19716319;   PMID:22820572;   PMID:23426701;   PMID:24363998;   PMID:3025043;   Patent:EP47109;   Patent:US4464382;   Reaxys:4236712;   Wikipedia:Epalrestat


show annotations for term's descendants           Sort by:
epalrestat term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Casp3 caspase 3 multiple interactions ISO epalrestat results in increased cleavage of and results in increased activity of CASP3 protein CTD PMID:28204799 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression ISO epalrestat results in increased expression of COL1A1 mRNA; epalrestat results in increased expression of COL1A1 protein CTD PMID:28204799 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Cygb cytoglobin increases expression ISO epalrestat results in increased expression of CYGB mRNA; epalrestat results in increased expression of CYGB protein CTD PMID:28204799 NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442 		JBrowse link
G Fgf21 fibroblast growth factor 21 increases expression ISO epalrestat results in increased expression of FGF21 mRNA CTD PMID:28204799 NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases expression ISO epalrestat results in increased expression of HIF1A mRNA CTD PMID:28204799 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO epalrestat results in increased expression of HMOX1 mRNA CTD PMID:28204799 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO epalrestat analog inhibits the reaction [Doxorubicin results in increased expression of and results in increased secretion of IL1B protein]; epalrestat analog inhibits the reaction [Doxorubicin results in increased secretion of IL1B protein]; epalrestat inhibits the reaction [Doxorubicin results in increased secretion of IL1B protein] CTD PMID:37257577 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO epalrestat analog inhibits the reaction [Doxorubicin results in increased expression of and results in increased secretion of IL6 protein]; epalrestat analog inhibits the reaction [Doxorubicin results in increased secretion of IL6 protein]; epalrestat inhibits the reaction [Doxorubicin results in increased secretion of IL6 protein] CTD PMID:37257577 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Itgad integrin subunit alpha D increases expression ISO epalrestat results in increased expression of ITGAD mRNA CTD PMID:28204799 NCBI chr 1:182,759,762...182,788,422
Ensembl chr 1:182,759,740...182,788,161 		JBrowse link
G Itgam integrin subunit alpha M increases expression ISO epalrestat results in increased expression of ITGAM mRNA CTD PMID:28204799 NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503 		JBrowse link
G Ldha lactate dehydrogenase A multiple interactions ISO epalrestat analog inhibits the reaction [Doxorubicin results in increased secretion of LDHA protein]; epalrestat inhibits the reaction [Doxorubicin results in increased secretion of LDHA protein] CTD PMID:37257577 NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO epalrestat affects the localization of and results in increased activity of NFE2L2 protein CTD PMID:28204799 NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Ngf nerve growth factor multiple interactions
increases secretion
increases expression		 EXP epalrestat inhibits the reaction [Streptozocin results in decreased expression of NGF protein]
epalrestat results in increased secretion of NGF protein
epalrestat results in increased expression of NGF protein		 CTD PMID:9628756 NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression ISO epalrestat results in increased expression of NQO1 mRNA CTD PMID:28204799 NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO epalrestat analog inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein]; epalrestat inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] CTD PMID:37257577 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO epalrestat inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268 		JBrowse link
G Sod2 superoxide dismutase 2 increases expression
multiple interactions		 ISO epalrestat results in increased expression of SOD2 mRNA
epalrestat analog inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein]; epalrestat inhibits the reaction [Doxorubicin results in decreased expression of SOD2 protein]		 CTD PMID:28204799 PMID:37257577 NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Sord sorbitol dehydrogenase multiple interactions ISO epalrestat inhibits the reaction [SORD protein mutant form results in increased abundance of Sorbitol] CTD PMID:32367058 NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133 		JBrowse link
G Tnf tumor necrosis factor increases expression
multiple interactions		 ISO epalrestat results in increased expression of TNF mRNA
epalrestat analog inhibits the reaction [Doxorubicin results in increased expression of and results in increased secretion of TNF protein]; epalrestat analog inhibits the reaction [Doxorubicin results in increased secretion of TNF protein]; epalrestat inhibits the reaction [Doxorubicin results in increased secretion of TNF protein]		 CTD PMID:28204799 PMID:37257577 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnnt2 troponin T2, cardiac type multiple interactions ISO epalrestat analog inhibits the reaction [Doxorubicin results in increased expression of TNNT2 protein]; epalrestat inhibits the reaction [Doxorubicin results in increased expression of TNNT2 protein] CTD PMID:37257577 NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388 		JBrowse link
G Trim63 tripartite motif containing 63 multiple interactions ISO epalrestat analog inhibits the reaction [Doxorubicin results in increased expression of TRIM63 protein]; epalrestat inhibits the reaction [Doxorubicin results in increased expression of TRIM63 protein] CTD PMID:37257577 NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19834
    role 19810
      chemical role 19445
        donor 18906
          Bronsted acid 18787
            oxoacid 18760
              carbon oxoacid 18633
                carboxylic acid 18630
                  monocarboxylic acid 18005
                    epalrestat 21
Path 2
Term Annotations click to browse term
  CHEBI ontology 19834
    subatomic particle 19832
      composite particle 19832
        hadron 19832
          baryon 19832
            nucleon 19832
              atomic nucleus 19832
                atom 19832
                  main group element atom 19782
                    p-block element atom 19782
                      carbon group element atom 19731
                        carbon atom 19727
                          organic molecular entity 19727
                            heteroorganic entity 19484
                              organochalcogen compound 19248
                                organooxygen compound 19165
                                  carbon oxoacid 18633
                                    carboxylic acid 18630
                                      monocarboxylic acid 18005
                                        epalrestat 21
paths to the root